The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of norgestimate/ethinyl estradiol on
lumbar spine (L1-L4) and total hip bone mineral density (BMD) in pediatric subjects with
anorexia nervosa.
Phase:
Phase 2
Details
Lead Sponsor:
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.